CPA3

Mast cell carboxypeptidase A · P15088 · CPA3 on Sugi Atlas →

6,976 patent compounds predicted against CPA3, 4,755 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL393002 SCHEMBL393002 1.00 3/20
SCHEMBL1915564 SCHEMBL1915564 1.00 3/20
SCHEMBL1719401 SCHEMBL1719401 0.72 3/20
SCHEMBL638640 SCHEMBL638640 0.70 3/20
SCHEMBL1859177 SCHEMBL1859177 0.70 3/20
SCHEMBL839261 SCHEMBL839261 0.68 3/20
SCHEMBL839262 SCHEMBL839262 0.68 3/20
SCHEMBL1114629 SCHEMBL1114629 0.68 3/20
SCHEMBL1177225 SCHEMBL1177225 0.68 3/20
SCHEMBL1915234 SCHEMBL1915234 0.68 3/20
SCHEMBL1915237 SCHEMBL1915237 0.68 3/20
SCHEMBL1915616 SCHEMBL1915616 0.68 3/20
SCHEMBL1373606 SCHEMBL1373606 0.66 3/20
Bromide Bromide (SCHEMBL1177352) 0.66 3/20
SCHEMBL265063 SCHEMBL265063 0.66 3/20
SCHEMBL265514 SCHEMBL265514 0.66 3/20
SCHEMBL491524 SCHEMBL491524 0.66 3/20
SCHEMBL558159 SCHEMBL558159 0.66 3/20
SCHEMBL429946 SCHEMBL429946 0.64 3/20
SCHEMBL1195866 SCHEMBL1195866 0.63 3/20

Clinical trials — most relevant to CPA3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients PHASE2/PHASE3COMPLETED
Effects of Anti-TSLP in Patients With Asthma PHASE2COMPLETED
A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis PHASE2COMPLETED
The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial Dose PHASE2COMPLETED
Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction EARLY_PHASE1COMPLETED
Chemokine Mechanisms in Chronic Pelvic Pain nanCOMPLETED
Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing nanCOMPLETED
Cause and Natural Course of Pediatric-Onset Mastocytosis nanCOMPLETED
Mast Cells and Its Proteases in COPD nanUNKNOWN
Allergy and Immunology Natural History Study nanRECRUITING
Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals nanCOMPLETED
Kinetics of Nasal Cytokine Responses to Mechanical Stimulation nanCOMPLETED
Pathogenesis of Physical Induced Urticarial Syndromes nanCOMPLETED
Cause of Unexplained Anaphylaxis nanACTIVE_NOT_RECRUITING
Persistence of Sensitization to Contrast Media nanNOT_YET_RECRUITING
Serum Basal Tryptase Levels in Healthy Children nanCOMPLETED
Tryptase Level as a Marker of Complications in Transcatheter Aortic Valve Replacement nanUNKNOWN
Mast Cell Activation Test in Allergic Disease nanCOMPLETED
The Utility of Serum Tryptase in the Diagnosis of Shrimp- Induced Anaphylaxis nanCOMPLETED
Effect of FODMAPs on Mucosal Inflammation in IBS Patients nanUNKNOWN
Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations nanCOMPLETED
Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma nanCOMPLETED
Contribution of Nasal IgE Production to the Boost of Systemic Allergen-specific IgE Upon Nasal Allergen Contact nanRECRUITING
Are Mast Cells Involved in Autoinflammatory Diseases nanNOT_YET_RECRUITING
Diagnosis and Allergen Identification of Perioperative Anaphylaxis nanRECRUITING
In Vivo Assessment of Histamine Pharmacodynamics nanWITHDRAWN
Role of Tryptase Levels in Patients With Stable Coronary Artery Disease. nanRECRUITING
Applying Systems Immunology to the Search for Personalized Biomarkers of Clinical Efficacy nanCOMPLETED
Perioperative Anaphylaxis in Patients Attending University Hospitals (Egypt - UK). nanCOMPLETED
GI Alpha-Gal Study nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CPA3 binder may also engage these)

ProteinNameSimilarity
Q9JHH6 0.998 Q9JHH6 →
CPA2 Carboxypeptidase A2 0.995 landscape →
P15089 0.995 P15089 →
P21961 0.993 P21961 →
Q9EQV9 0.991 Q9EQV9 →
Q0II73 0.991 Q0II73 →
Q2KIG3 0.990 Q2KIG3 →
B8JLQ9 0.990 B8JLQ9 →
P09955 0.989 P09955 →
P09954 0.988 P09954 →
Q8WXQ8 0.988 Q8WXQ8 →
P19223 0.988 P19223 →
CPA4 Carboxypeptidase A4 0.988 landscape →
CPB1 Carboxypeptidase B 0.987 landscape →
P38836 0.986 P38836 →
P00732 0.986 P00732 →
Q6P8K8 0.986 Q6P8K8 →
P55261 0.986 P55261 →
D4D675 0.984 D4D675 →
CPB2 Carboxypeptidase B2 0.984 landscape →
Q3T905 0.983 Q3T905 →
O02350 0.983 O02350 →
Q8R4H4 0.983 Q8R4H4 →
P37892 0.981 P37892 →
Q9VL86 0.981 Q9VL86 →
Q4R7R2 0.981 Q4R7R2 →
A0A1S4F020 0.981 A0A1S4F020 →
P00730 0.981 P00730 →
Q10916 0.981 Q10916 →
B6V865 0.981 B6V865 →